{"disease":{"id":"prostatic-hyperplasia","name":"prostatic hyperplasia"},"drugs":{"marketed":[{"drug_id":"doxazosin-mesylate","indication_name":"Benign Prostatic Hyperplasia (BPH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DOXAZOSIN MESYLATE","company_name":"","drug_phase":"marketed","molecular_target":"alpha 1 adrenoceptor","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Doxazosin selectively blocks alpha 1 adrenoceptors, reducing urethral resistance and systemic vascular resistance."},{"drug_id":"alfuzosin-hydrochloride","indication_name":"Benign Prostatic Hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALFUZOSIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"alpha 1-adrenoreceptors","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Alfuzosin blocks post-synaptic alpha 1-adrenoreceptors in the prostate and bladder areas to relax smooth muscle."},{"drug_id":"terazosin-hydrochloride","indication_name":"Symptomatic Benign Prostatic Hyperplasia (BPH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TERAZOSIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"tadalafil","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cialis","generic_name":"tadalafil","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"Phosphodiesterase 5 Inhibitor [EPC]","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"tamsulosin","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flomax","generic_name":"tamsulosin","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"doxazosin","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardura","generic_name":"DOXAZOSIN","company_name":"Viatris","drug_phase":"marketed","molecular_target":"Alpha-1B adrenergic receptor","drug_class":"alpha-Adrenergic Blocker","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"cialis","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cialis","company_name":"Ottawa Hospital Research Institute","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naftopidil","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flivas","generic_name":"NAFTOPIDIL","company_name":"Asahi Kasei","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"naftopidil","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"silodosin","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rapaflo","generic_name":"SILODOSIN","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"alpha-1 adrenoreceptors","drug_class":"alpha-Adrenergic Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Silodosin blocks alpha-1 adrenoreceptors in the prostate and bladder, causing smooth muscle relaxation and improving urine flow."},{"drug_id":"terazosin","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hytrin","generic_name":"TERAZOSIN","company_name":"","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Blocker","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"alfuzosin","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uroxatral","generic_name":"ALFUZOSIN","company_name":"Advanz","drug_phase":"marketed","molecular_target":"alpha 1-adrenoreceptors","drug_class":"alpha-Adrenergic Blocker","quality_score":10,"revenue":null,"mechanism":"Alfuzosin blocks post-synaptic alpha 1-adrenoreceptors in the prostate and bladder areas to relax smooth muscle."},{"drug_id":"terazosine","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Terazosine","company_name":"University of Iowa","drug_phase":"phase_2","molecular_target":"Ribosyldihydronicotinamide dehydrogenase [quinone], Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"avodart","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Avodart","company_name":"GlaxoSmithKline","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 1, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Glycine receptor subunit alpha-1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"dutasteride","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avodart","generic_name":"dutasteride","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 1, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Glycine receptor subunit alpha-1","drug_class":"5-alpha-reductase inhibitor (dual)","quality_score":null,"revenue":null,"mechanism":"Dual 5-alpha-reductase inhibitor (types I and II) that more completely suppresses DHT than finasteride for BPH treatment."},{"drug_id":"finasteride","indication_name":"Benign prostatic hyperplasia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Propecia","generic_name":"finasteride","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1, Cytochrome P450 2C19, Cytochrome P450 2C9","drug_class":"5-alpha-reductase inhibitor","quality_score":null,"revenue":null,"mechanism":"Selective type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), treating BPH and male pattern hair loss."}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03354416","title":"Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07159165","title":"Registry of MIUS for Benign Prostatic Obstruction","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"Ondokuz Mayıs University","has_results":false},{"nct_id":"NCT06182189","title":"Protocollo N 2014 - Benign Prostatic Hyperplasia","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05463796","title":"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05422677","title":"An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia","phase":"","overall_status":"COMPLETED","enrollment_count":4698,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT07242807","title":"Minimally Invasive Prostate Interventions Registry (MIST Study)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Necmettin Erbakan University","has_results":false},{"nct_id":"NCT05292235","title":"Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT02757963","title":"Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1679,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06589154","title":"The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":1651,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT04726748","title":"Economic Evaluation of Prostatic Urethral Lift","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1360,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT01018511","title":"Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1334,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT04831476","title":"Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)","phase":"","overall_status":"COMPLETED","enrollment_count":1296,"lead_sponsor_name":"Elpen Pharmaceutical Co. Inc.","has_results":false},{"nct_id":"NCT01021332","title":"Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1067,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT07417449","title":"Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT06546735","title":"Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":816,"lead_sponsor_name":"Eurofarma Laboratorios S.A.","has_results":false},{"nct_id":"NCT02972268","title":"Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":780,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT01294592","title":"Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":742,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02757768","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":715,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT03479359","title":"Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04947631","title":"Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":667,"lead_sponsor_name":"Dongkook Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03179670","title":"Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH","phase":"","overall_status":"COMPLETED","enrollment_count":625,"lead_sponsor_name":"RECORDATI GROUP","has_results":false},{"nct_id":"NCT02058368","title":"Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00127179","title":"A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT07357714","title":"Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT03554070","title":"Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT06852859","title":"Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT03521648","title":"Database for the Assessment of Efficacy and Safety of BPH Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Dominik Abt","has_results":false},{"nct_id":"NCT06560476","title":"OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Urotronic Inc.","has_results":false},{"nct_id":"NCT03527589","title":"Embosphere® PROstate Post Market Study","phase":"","overall_status":"COMPLETED","enrollment_count":499,"lead_sponsor_name":"Merit Medical Systems, Inc.","has_results":true},{"nct_id":"NCT01777269","title":"Prospective Sexual Function Study for BPH Subjects","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":489,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03230721","title":"ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH","phase":"NA","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT06528613","title":"Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Elpen Pharmaceutical Co. Inc.","has_results":false},{"nct_id":"NCT04032067","title":"Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":423,"lead_sponsor_name":"GemVax & Kael","has_results":false},{"nct_id":"NCT04648176","title":"Application of MOSES Technology in BPH","phase":"NA","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT04577040","title":"Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT03297281","title":"Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)","phase":"NA","overall_status":"RECRUITING","enrollment_count":389,"lead_sponsor_name":"Clinique Pasteur","has_results":false},{"nct_id":"NCT00368979","title":"Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06380062","title":"Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Universität des Saarlandes","has_results":false},{"nct_id":"NCT05574244","title":"Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction","phase":"NA","overall_status":"RECRUITING","enrollment_count":336,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT05116592","title":"The Risk Factor and Outcome of Transient Incontinence After Prostate Enucleation Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":330,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT01107392","title":"Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05551221","title":"The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":312,"lead_sponsor_name":"Xintian Pharmaceutical","has_results":false},{"nct_id":"NCT05585450","title":"Effect of Electroacupuncture on Benign Prostatic Hyperplasia","phase":"NA","overall_status":"RECRUITING","enrollment_count":306,"lead_sponsor_name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT06656689","title":"Study on Water Vapor Thermal Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Saint Vincent's Hospital, Korea","has_results":false},{"nct_id":"NCT05023824","title":"Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT04185441","title":"Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":295,"lead_sponsor_name":"EMS","has_results":false},{"nct_id":"NCT03157726","title":"Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate","phase":"NA","overall_status":"UNKNOWN","enrollment_count":294,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT07144709","title":"A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia","phase":"","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Pierre Fabre Medicament","has_results":false},{"nct_id":"NCT03583034","title":"Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands","phase":"","overall_status":"UNKNOWN","enrollment_count":275,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04446429","title":"Anti-Androgen Treatment for COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":268,"lead_sponsor_name":"Applied Biology, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}